Literature DB >> 12738650

Effect of glycosphingolipids purified from Leishmania (Leishmania) amazonensis amastigotes on human peripheral lymphocytes.

Selma Giorgio1, Marcia Regina M Santos, Anita H Straus, Helio K Takahashi, Clara Lúcia Barbiéri.   

Abstract

The effect of purified glycosphingolipids from Leishmania (Leishmania) amazonensis on human lymphoproliferation, on expression of human lymphocyte and monocyte markers (CD3, CD4, CD8, CD14, CD19, and CD45), and on lymphocyte protein kinase C activity was analyzed.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12738650      PMCID： PMC154971          DOI： 10.1128/cdli.10.3.469-472.2003

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


  21 in total

1.  Inhibitory effects on protein kinase C activity by lipophosphoglycan fragments and glycosylphosphatidylinositol antigens of the protozoan parasite Leishmania.

Authors:  T B McNeely; G Rosen; M V Londner; S J Turco
Journal:  Biochem J       Date:  1989-04-15       Impact factor: 3.857

Review 2.  Functional role of glycosphingolipids in cell recognition and signaling.

Authors:  S Hakomori; Y Igarashi
Journal:  J Biochem       Date:  1995-12       Impact factor: 3.387

3.  Requirement of lipophosphoglycan for intracellular survival of Leishmania donovani within human monocytes.

Authors:  T B McNeely; S J Turco
Journal:  J Immunol       Date:  1990-04-01       Impact factor: 5.422

4.  Transbilayer inhibition of protein kinase C by the lipophosphoglycan from Leishmania donovani.

Authors:  J R Giorgione; S J Turco; R M Epand
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

Review 5.  Bifunctional role of glycosphingolipids. Modulators for transmembrane signaling and mediators for cellular interactions.

Authors:  S Hakomori
Journal:  J Biol Chem       Date:  1990-11-05       Impact factor: 5.157

6.  Glycosphingolipid antigens of Leishmania (Leishmania) amazonensis amastigotes identified by use of a monoclonal antibody.

Authors:  C L Barbiéri; S Giorgio; A J Merjan; E N Figueiredo
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

7.  Inhibition of mouse lymphocyte proliferative response by glycosphingolipids from Leishmania (L.) amazonensis.

Authors:  S Giorgio; M G Jasiulionis; A H Straus; H K Takahashi; C L Barbiéri
Journal:  Exp Parasitol       Date:  1992-08       Impact factor: 2.011

Review 8.  Functions of sphingolipids and sphingolipid breakdown products in cellular regulation.

Authors:  Y A Hannun; R M Bell
Journal:  Science       Date:  1989-01-27       Impact factor: 47.728

Review 9.  The lipophosphoglycan of Leishmania parasites.

Authors:  S J Turco; A Descoteaux
Journal:  Annu Rev Microbiol       Date:  1992       Impact factor: 15.500

10.  Stage-specific glycosphingolipids from amastigote forms of Leishmania (L.) amazonensis. Immunogenicity and role in parasite binding and invasion of macrophages.

Authors:  A H Straus; S B Levery; M G Jasiulionis; M E Salyan; S J Steele; L R Travassos; S Hakomori; H K Takahashi
Journal:  J Biol Chem       Date:  1993-06-25       Impact factor: 5.157
View more
  3 in total

Review 1.  Role of sphingolipids in microbial pathogenesis.

Authors:  Lena J Heung; Chiara Luberto; Maurizio Del Poeta
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

2.  Glycolipid sensing and innate immunity in paracoccidioidomycosis.

Authors:  Vanessa G Batista; Marcos S Toledo; Anita H Straus; Maria J S Mendes-Giannini; Alberto J S Duarte; Helio K Takahashi; Gil Benard
Journal:  Mycopathologia       Date:  2014-07-16       Impact factor: 2.574

3.  A sphingolipid rich lipid fraction isolated from attenuated Leishmania donovani promastigote induces apoptosis in mouse and human melanoma cells in vitro.

Authors:  Jagnyeswar Ratha; Kajal Nayan Majumdar; Sushil Kumar Mandal; Rabindranath Bera; Chinmoy Sarkar; Bidisha Saha; Chitra Mandal; Krishna Das Saha; Ranjan Bhadra
Journal:  Mol Cell Biochem       Date:  2006-05-23       Impact factor: 3.396
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.